首页 > 最新文献

Phlebology最新文献

英文 中文
Core content for venous and Lymphatic Medicine: 2022 revision. 静脉和淋巴医学的核心内容:2022年修订版。
Pub Date : 2024-07-01 Epub Date: 2023-11-07 DOI: 10.1177/02683555231212302
N M Khilnani, S M Wasan, P J Pappas, Z Deol, J P Schoonover, S F Daugherty, R R Attaran, T V Cartee, T M Straight, J Fish, J W Granzow, R S Winokur, K R Desai, G Salazar, J Stoughton, K Gibson, A D Jones, J M Lohr, S Vayuvegula, M H Meissner

The core content for a medical specialty outlines the scope of the discipline as well as the categories of knowledge considered essential to practice in the field. It provides a template for the development of curricula for medical school, graduate, and postgraduate education, as well as for creating certification standards. Venous and Lymphatic Medicine (VLM) is a specialty that has benefitted from contributions from specialists from several medical disciplines. Optimally, the societies, boards, and residency review committees representing these disciplines would uniformly recognize the scope of VLM to develop education and assessment standards to allow training and identification of qualified practitioners. In order to inform the standard setting bodies and other stakeholders of the current scope of VLM, a task force of VLM experts from cardiology, dermatology, emergency medicine, general surgery, interventional radiology, vascular medicine, and vascular surgery was formed to revise a 2014 consensus document defining the core content of the specialty of VLM.

医学专业的核心内容概述了该学科的范围以及被认为对该领域的实践至关重要的知识类别。它为医学院、研究生和研究生教育课程的制定以及认证标准的制定提供了模板。静脉和淋巴医学(VLM)是一个受益于多个医学学科专家贡献的专业。最理想的情况是,代表这些学科的协会、董事会和居住审查委员会将统一承认VLM的范围,以制定教育和评估标准,从而培训和识别合格的从业者。为了向标准制定机构和其他利益相关者通报VLM的当前范围,成立了一个由来自心脏病学、皮肤病学、急诊医学、普通外科、介入放射学、血管医学和血管外科的VLM专家组成的工作组,以修订2014年的共识文件,该文件定义了VLM专业的核心内容。
{"title":"Core content for venous and Lymphatic Medicine: 2022 revision.","authors":"N M Khilnani, S M Wasan, P J Pappas, Z Deol, J P Schoonover, S F Daugherty, R R Attaran, T V Cartee, T M Straight, J Fish, J W Granzow, R S Winokur, K R Desai, G Salazar, J Stoughton, K Gibson, A D Jones, J M Lohr, S Vayuvegula, M H Meissner","doi":"10.1177/02683555231212302","DOIUrl":"10.1177/02683555231212302","url":null,"abstract":"<p><p>The core content for a medical specialty outlines the scope of the discipline as well as the categories of knowledge considered essential to practice in the field. It provides a template for the development of curricula for medical school, graduate, and postgraduate education, as well as for creating certification standards. Venous and Lymphatic Medicine (VLM) is a specialty that has benefitted from contributions from specialists from several medical disciplines. Optimally, the societies, boards, and residency review committees representing these disciplines would uniformly recognize the scope of VLM to develop education and assessment standards to allow training and identification of qualified practitioners. In order to inform the standard setting bodies and other stakeholders of the current scope of VLM, a task force of VLM experts from cardiology, dermatology, emergency medicine, general surgery, interventional radiology, vascular medicine, and vascular surgery was formed to revise a 2014 consensus document defining the core content of the specialty of VLM.</p>","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"365-378"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71490924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The sonographic features of lymph node venous networks and flow patterns in patients with primary chronic venous disease. 原发性慢性静脉疾病患者淋巴结静脉网络和血流模式的声像图特征。
Pub Date : 2024-07-01 Epub Date: 2024-03-11 DOI: 10.1177/02683555241238770
Gaorui Liu, Jillian Clarke, Yong Liu, Yunwei Zhang, Irwin Mohan

Background: Our study aims to enhance the understanding of lymph node venous networks (LNVNs) by summarising their anatomical, sonographic features, and reflux patterns.

Method: We examined 241 legs from 141 patients with primary chronic venous disease (CVD) using duplex ultrasound.

Results: The findings indicated variations in the shape, size, vascularity, and echogenicity of LNVN. The superficial inguinal lymph node with reflux appeared slightly larger, exhibiting higher velocities in the hilar artery. Regarding connections, venous flow within LNVN was predominantly drained through the saphenofemoral junction (SFJ), anterior accessory great saphenous vein (AAGSV), and great saphenous vein (GSV). A significant number of LNVNs were observed to be associated with anterolateral thigh tributaries. The study also identified valve cusps within LNVN.

Conclusion: This study revealed a 12% prevalence of primary LNVN. Understanding the anatomical and haemodynamic features of LNVN informs treatment strategies and potentially helps prevent the recurrence of varicose veins.

研究背景我们的研究旨在通过总结淋巴结静脉网(LNVN)的解剖学、声像图特征和回流模式,加深对淋巴结静脉网的了解:方法:我们使用双工超声波检查了 141 名原发性慢性静脉疾病(CVD)患者的 241 条腿:结果:研究结果表明,腹股沟浅表淋巴结的形状、大小、血管和回声存在差异。出现反流的腹股沟浅淋巴结看起来稍大,在腹股沟动脉中的速度较高。在连接方面,LNVN 内的静脉流主要通过隐股交界处(SFJ)、大隐静脉前附件(AAGSV)和大隐静脉(GSV)引流。据观察,大量 LNVN 与大腿前外侧支流有关。研究还在 LNVN 中发现了瓣膜尖头:这项研究显示,原发性 LNVN 的发病率为 12%。了解 LNVN 的解剖和血流动力学特征可为治疗策略提供参考,并有助于预防静脉曲张复发。
{"title":"The sonographic features of lymph node venous networks and flow patterns in patients with primary chronic venous disease.","authors":"Gaorui Liu, Jillian Clarke, Yong Liu, Yunwei Zhang, Irwin Mohan","doi":"10.1177/02683555241238770","DOIUrl":"10.1177/02683555241238770","url":null,"abstract":"<p><strong>Background: </strong>Our study aims to enhance the understanding of lymph node venous networks (LNVNs) by summarising their anatomical, sonographic features, and reflux patterns.</p><p><strong>Method: </strong>We examined 241 legs from 141 patients with primary chronic venous disease (CVD) using duplex ultrasound.</p><p><strong>Results: </strong>The findings indicated variations in the shape, size, vascularity, and echogenicity of LNVN. The superficial inguinal lymph node with reflux appeared slightly larger, exhibiting higher velocities in the hilar artery. Regarding connections, venous flow within LNVN was predominantly drained through the saphenofemoral junction (SFJ), anterior accessory great saphenous vein (AAGSV), and great saphenous vein (GSV). A significant number of LNVNs were observed to be associated with anterolateral thigh tributaries. The study also identified valve cusps within LNVN.</p><p><strong>Conclusion: </strong>This study revealed a 12% prevalence of primary LNVN. Understanding the anatomical and haemodynamic features of LNVN informs treatment strategies and potentially helps prevent the recurrence of varicose veins.</p>","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"414-427"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140103095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Anterior Saphenous Vein. Part 2. Anatomic considerations in normal and refluxing patients. Endorsed by the American Vein and Lymphatic Society, the American Venous Forum and the International Union of Phlebology. 隐静脉前端。第二部分。正常和反流患者的解剖学考虑。由美国静脉和淋巴协会、美国静脉论坛和国际静脉学联盟认可。
Pub Date : 2024-06-01 Epub Date: 2024-03-25 DOI: 10.1177/02683555231223055
Alberto Caggiati, Nicos Labropoulos, Edward M Boyle, Rachel Drgastin, Antonios Gasparis, Suat Doganci, Mark Meissner

Background: The term Anterior Accessory of the Great Saphenous Vein suggest this is a branch tributary vein despite this vessel's anatomic features of a truncal vein. A multisocietal group suggested to designate this the Anterior Saphenous Vein (ASV). This study was aimed to evaluate its ultrasound anatomy in normal and varicose limbs.

Methods: The clinical anatomy of the ASV was evaluated by narrative review of the literature. Additionally, the course of the ASV was evaluated in 62 limbs with no evidence of venous disease and 62 limbs with varicosities.

Results: The ASV length, patterns of origin and termination are reported in both normal and patients with varicose veins. Discussion of the patterns is supported by the narrative review of the literature.

Conclusions: The ASV must be considered a truncal vein and its treatment modalities should be the same that for the great and small saphenous veins rather than a tributary vein.

背景:尽管大隐静脉的解剖学特征是躯干静脉,但 "大隐静脉前附件"(Anterior Accessory of the Great Saphenous Vein)一词表明这是一条支流静脉。一个多社会团体建议将其命名为前大隐静脉(ASV)。本研究旨在评估其在正常肢体和静脉曲张肢体中的超声解剖情况:方法:通过回顾文献对 ASV 的临床解剖进行评估。此外,还评估了 62 条无静脉疾病迹象的肢体和 62 条静脉曲张肢体的 ASV 走向:结果:正常静脉和静脉曲张患者的 ASV 长度、起源和终止模式均有报道。结果:报告了正常静脉和静脉曲张患者的 ASV 长度、起始和终止模式,对这些模式的讨论得到了文献综述的支持:结论:ASV 必须被视为躯干静脉,其治疗方法应与大隐静脉和小隐静脉相同,而非支流静脉。
{"title":"The Anterior Saphenous Vein. Part 2. Anatomic considerations in normal and refluxing patients. Endorsed by the American Vein and Lymphatic Society, the American Venous Forum and the International Union of Phlebology.","authors":"Alberto Caggiati, Nicos Labropoulos, Edward M Boyle, Rachel Drgastin, Antonios Gasparis, Suat Doganci, Mark Meissner","doi":"10.1177/02683555231223055","DOIUrl":"10.1177/02683555231223055","url":null,"abstract":"<p><strong>Background: </strong>The term Anterior Accessory of the Great Saphenous Vein suggest this is a branch tributary vein despite this vessel's anatomic features of a truncal vein. A multisocietal group suggested to designate this the Anterior Saphenous Vein (ASV). This study was aimed to evaluate its ultrasound anatomy in normal and varicose limbs.</p><p><strong>Methods: </strong>The clinical anatomy of the ASV was evaluated by narrative review of the literature. Additionally, the course of the ASV was evaluated in 62 limbs with no evidence of venous disease and 62 limbs with varicosities.</p><p><strong>Results: </strong>The ASV length, patterns of origin and termination are reported in both normal and patients with varicose veins. Discussion of the patterns is supported by the narrative review of the literature.</p><p><strong>Conclusions: </strong>The ASV must be considered a truncal vein and its treatment modalities should be the same that for the great and small saphenous veins rather than a tributary vein.</p>","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"313-324"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11129527/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140290130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Third generation of laser (>1900) for endovenous thermoablation (EVLA) of varicose veins: A systematic review and meta-analysis. 用于静脉曲张静脉腔内热消融术(EVLA)的第三代激光器(>1900):系统回顾和荟萃分析。
Pub Date : 2024-06-01 Epub Date: 2024-01-10 DOI: 10.1177/02683555241227017
Luca Palombi, Monica Morelli, Dario Bruzzese, Gennaro Quarto

Objectives: Third generation lasers with longer wavelengths (>1900 nm) have been introduced, in recent years, for the treatment of varicose veins. The possible advantage of the new generation lasers is that they allow complete damage to the vein wall using a lower Power in Watts (W: J/sec) and a lower linear energy density (LEED: J/cm). The aim of this work is to evaluate the results present in the literature regarding efficacy and safeness of the new generation lasers for the treatment of varicose veins.

Methods: Published articles were searched on PubMed database and on Cochrane Library, entering the keywords "1940 nm or 1920 nm laser AND varicose veins laser thermoablation (EVLA)." The primary endpoint of the study was to value rate of occlusion and adverse events at the short term follow-up. The search yielded a total of 14 studies. In the end, only six studies were judge eligibility.

Results: The studies were heterogenous in their documentation, EVLA, duplex ultrasound protocol and result reporting. A total of 540 limbs of 377 patients were treated with endovenous laser ablation (EVLA) with laser 1920-1940 nm. The treated veins had a mean diameter of 0.74 ± 0.17 cm and a mean length of 27.87 ± 20.63 cm. The pooled estimates of immediate occlusion rate was of 99.8% (95% CI: 97.9% to 100.0) with high heterogeneity (I2 = 60%; 95% PI: 89.7% to 100%), while at short-term follow-up was of 98.2% (95% CI: 94.0% to 100.0%) with higher heterogeneity (I2:79%; 95% PI: 77.1% to 100.0%). EHIT occurred in 7 cases (pooled estimate: 0.7%). The other adverse events rate reported were 1% of hyperpigmentation, 2.8% of neurological complications, 0.6% thrombophlebitis and 1.9% of bruising/hematoma. The pooled mean estimates of LEED was equal to 38.2 J/cm (95% CI: 26.3 to 50.1 J/cm) although with a very large heterogeneity (I2 = 100%).

Conclusions: The overall success rate of EVLA was high. The analysis of these studies suggests that using lower parameters (Power and linear administered energy) may have no effect on the treatment success rate. Short-term results demonstrate comparable occlusion rates respect the second-generation lasers. Instead, data suggest a low complication rates. Short-term results demonstrate comparable complications rates respect the second-generation lasers (1300-1470 nm). Randomized studies with longer follow-up are required to evaluate the EVLA 1900 nm procedure further.

目的:近年来,用于治疗静脉曲张的第三代激光器波长更长(大于 1900 纳米)。新一代激光的可能优势在于,它们能以较低的瓦特功率(W:焦耳/秒)和较低的线性能量密度(LEED:焦耳/厘米)完全破坏静脉壁。这项工作的目的是评估文献中有关新一代激光治疗静脉曲张的有效性和安全性的结果:方法:在PubMed数据库和Cochrane图书馆中输入关键词 "1940 nm或1920 nm激光和静脉曲张激光热消融术(EVLA)"搜索已发表的文章。研究的主要终点是评估短期随访的闭塞率和不良事件。搜索结果共涉及 14 项研究。最终,只有六项研究获得了评审资格:这些研究在文件记录、EVLA、双相超声方案和结果报告方面存在差异。共有 377 名患者的 540 条肢体接受了静脉腔内激光消融术(EVLA)治疗,激光波长为 1920-1940 nm。治疗后的静脉平均直径为 0.74 ± 0.17 厘米,平均长度为 27.87 ± 20.63 厘米。即刻闭塞率的汇总估计值为99.8%(95% CI:97.9%至100.0%),异质性较高(I2=60%;95% PI:89.7%至100%);短期随访的即刻闭塞率为98.2%(95% CI:94.0%至100.0%),异质性较高(I2:79%;95% PI:77.1%至100.0%)。7例发生了EHIT(汇总估计值:0.7%)。其他不良事件报告率为:色素沉着 1%、神经系统并发症 2.8%、血栓性静脉炎 0.6%、瘀伤/血肿 1.9%。LEED的集合平均估计值为38.2 J/cm(95% CI:26.3至50.1 J/cm),但存在很大的异质性(I2 = 100%):EVLA的总体成功率很高。对这些研究的分析表明,使用较低的参数(功率和线性给药能量)可能对治疗成功率没有影响。短期结果显示,与第二代激光器相比,闭塞率相当。相反,数据表明并发症发生率较低。短期结果显示,第二代激光器(1300-1470 纳米)的并发症发生率相当。要进一步评估 EVLA 1900 nm 手术,还需要进行更长时间的随访随机研究。
{"title":"Third generation of laser (>1900) for endovenous thermoablation (EVLA) of varicose veins: A systematic review and meta-analysis.","authors":"Luca Palombi, Monica Morelli, Dario Bruzzese, Gennaro Quarto","doi":"10.1177/02683555241227017","DOIUrl":"10.1177/02683555241227017","url":null,"abstract":"<p><strong>Objectives: </strong>Third generation lasers with longer wavelengths (>1900 nm) have been introduced, in recent years, for the treatment of varicose veins. The possible advantage of the new generation lasers is that they allow complete damage to the vein wall using a lower Power in Watts (W: J/sec) and a lower linear energy density (LEED: J/cm). The aim of this work is to evaluate the results present in the literature regarding efficacy and safeness of the new generation lasers for the treatment of varicose veins.</p><p><strong>Methods: </strong>Published articles were searched on PubMed database and on Cochrane Library, entering the keywords \"1940 nm or 1920 nm laser AND varicose veins laser thermoablation (EVLA).\" The primary endpoint of the study was to value rate of occlusion and adverse events at the short term follow-up. The search yielded a total of 14 studies. In the end, only six studies were judge eligibility.</p><p><strong>Results: </strong>The studies were heterogenous in their documentation, EVLA, duplex ultrasound protocol and result reporting. A total of 540 limbs of 377 patients were treated with endovenous laser ablation (EVLA) with laser 1920-1940 nm. The treated veins had a mean diameter of 0.74 ± 0.17 cm and a mean length of 27.87 ± 20.63 cm. The pooled estimates of immediate occlusion rate was of 99.8% (95% CI: 97.9% to 100.0) with high heterogeneity (I<sup>2</sup> = 60%; 95% PI: 89.7% to 100%), while at short-term follow-up was of 98.2% (95% CI: 94.0% to 100.0%) with higher heterogeneity (I<sup>2</sup>:79%; 95% PI: 77.1% to 100.0%). EHIT occurred in 7 cases (pooled estimate: 0.7%). The other adverse events rate reported were 1% of hyperpigmentation, 2.8% of neurological complications, 0.6% thrombophlebitis and 1.9% of bruising/hematoma. The pooled mean estimates of LEED was equal to 38.2 J/cm (95% CI: 26.3 to 50.1 J/cm) although with a very large heterogeneity (I<sup>2</sup> = 100%).</p><p><strong>Conclusions: </strong>The overall success rate of EVLA was high. The analysis of these studies suggests that using lower parameters (Power and linear administered energy) may have no effect on the treatment success rate. Short-term results demonstrate comparable occlusion rates respect the second-generation lasers. Instead, data suggest a low complication rates. Short-term results demonstrate comparable complications rates respect the second-generation lasers (1300-1470 nm). Randomized studies with longer follow-up are required to evaluate the EVLA 1900 nm procedure further.</p>","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"293-301"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139418915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The clinical and economic impact of chronic venous insufficiency-associated lymphedema and the prevalence of persistent edema after venous intervention. 慢性静脉功能不全相关淋巴水肿的临床和经济影响以及静脉干预后持续水肿的发生率。
Pub Date : 2024-06-01 Epub Date: 2024-02-12 DOI: 10.1177/02683555241233355
Matthew Genet, Nicos Labropoulos, Antonios Gasparis, Thomas O'Donnell, Kush Desai

Objectives: To determine the demographics, outcomes, and healthcare utilization of patients with chronic venous insufficiency-associated lymphedema (CVI-LED) and the prevalence of lymphedema-specific therapy use after venous intervention.

Methods: The IBM MarketScan Commercial and Medicare Claims Databases were examined for patients with CVI-LED. Patient demographics and the use of lymphedema-specific therapy before and after venous intervention were collected.

Results: Of 85,601 LED patients identified, 8,406 also had a diagnosis of CVI. In the CVI-LED group, 1051 underwent endovenous ablation or venous stent placement. The use of lymphedema-specific therapy before and after venous intervention was 52% and 39%, respectively (p < .05). The mean time of initiation of LED-specific therapy following venous intervention was 265 days after ablation and 347 days after stent placement.

Conclusion: Treating venous hypertension improves certain venous-related signs and symptoms of CVI. However, a significant proportion of patients have persistent edema which may reflect underlying, sub-optimally treated LED.

目的确定慢性静脉功能不全相关淋巴水肿(CVI-LED)患者的人口统计学特征、治疗效果和医疗保健利用率,以及静脉干预后使用淋巴水肿特异性疗法的流行率:对 IBM MarketScan 商业和医疗保险索赔数据库中的 CVI-LED 患者进行了研究。方法:对 IBM MarketScan 商业数据库和医疗保险索赔数据库中的 CVI-LED 患者进行检查,收集患者的人口统计数据以及静脉干预前后淋巴水肿特异性疗法的使用情况:结果:在确定的 85,601 名 LED 患者中,有 8,406 人同时被诊断为 CVI。在 CVI-LED 组中,有 1051 人接受了静脉腔内消融术或静脉支架置入术。静脉介入治疗前后使用淋巴水肿特异性疗法的比例分别为 52% 和 39%(P < .05)。静脉介入治疗后开始使用淋巴水肿特异性疗法的平均时间为消融术后265天,支架置入术后347天:结论:治疗静脉高压可改善 CVI 某些与静脉相关的体征和症状。结论:治疗静脉高血压可改善某些与静脉相关的症状和体征,但相当一部分患者会出现持续性水肿,这可能反映了潜在的、未得到最佳治疗的 LED。
{"title":"The clinical and economic impact of chronic venous insufficiency-associated lymphedema and the prevalence of persistent edema after venous intervention.","authors":"Matthew Genet, Nicos Labropoulos, Antonios Gasparis, Thomas O'Donnell, Kush Desai","doi":"10.1177/02683555241233355","DOIUrl":"10.1177/02683555241233355","url":null,"abstract":"<p><strong>Objectives: </strong>To determine the demographics, outcomes, and healthcare utilization of patients with chronic venous insufficiency-associated lymphedema (CVI-LED) and the prevalence of lymphedema-specific therapy use after venous intervention.</p><p><strong>Methods: </strong>The IBM MarketScan Commercial and Medicare Claims Databases were examined for patients with CVI-LED. Patient demographics and the use of lymphedema-specific therapy before and after venous intervention were collected.</p><p><strong>Results: </strong>Of 85,601 LED patients identified, 8,406 also had a diagnosis of CVI. In the CVI-LED group, 1051 underwent endovenous ablation or venous stent placement. The use of lymphedema-specific therapy before and after venous intervention was 52% and 39%, respectively (<i>p</i> < .05). The mean time of initiation of LED-specific therapy following venous intervention was 265 days after ablation and 347 days after stent placement.</p><p><strong>Conclusion: </strong>Treating venous hypertension improves certain venous-related signs and symptoms of CVI. However, a significant proportion of patients have persistent edema which may reflect underlying, sub-optimally treated LED.</p>","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"353-358"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139725615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selected Phlebological Abstracts. 静脉学摘要选编》。
Pub Date : 2024-06-01 Epub Date: 2024-05-08 DOI: 10.1177/02683555241252558
Lowell S Kabnick, Kathleen Ozsvath, Jorge H Ulloa
{"title":"Selected Phlebological Abstracts.","authors":"Lowell S Kabnick, Kathleen Ozsvath, Jorge H Ulloa","doi":"10.1177/02683555241252558","DOIUrl":"10.1177/02683555241252558","url":null,"abstract":"","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"359-360"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140892414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The anterior saphenous vein. Part 4. Clinical and technical considerations in treatment. Endorsed by the American Vein and Lymphatic Society, the American Venous Forum, and the International Union of Phlebology. 隐静脉前端。第 4 部分。治疗中的临床和技术考虑因素。由美国静脉和淋巴协会、美国静脉论坛和国际静脉学联盟认可。
Pub Date : 2024-06-01 Epub Date: 2023-12-21 DOI: 10.1177/02683555231223063
Edward M Boyle, Rachel Drgastin, Nicos Labropoulos, Alberto Caggiati, Antonios Gasparis, Suat Doganci, Mark Meissner

Background: The decision to treat a refluxing anterior saphenous vein (ASV) should be a clinical decision based on the assessment on the ASV's contribution to patient's signs and symptoms. Once the decision to treat has been made, there are anatomic, clinical, and technical considerations in treatment planning.

Methods: Clinical scenarios were discussed by a panel of experts and common anatomic, clinical, and technical considerations were identified.

Results: There are unique clinical considerations such as whether both the great saphenous vein (GSV) and ASV should be concomitantly treated, if a normal ASV should be treated when treating a refluxing GSV and when and how to treat the associated tributary varicose tributaries. Being aware of the anatomic, clinical, and technical considerations allows development of a treatment plan that optimizes long-term outcomes in patients with ASV reflux.

Conclusion: Ultimately the treatment plan should be tailored to address these types of variables in a patient-centered discussion.

背景:治疗反流隐前静脉(ASV)的决定应根据对ASV对患者体征和症状影响的评估做出临床决定。一旦决定进行治疗,在制定治疗计划时就需要考虑解剖、临床和技术因素:方法:由专家小组讨论临床情景,并确定常见的解剖、临床和技术考虑因素:结果:有一些独特的临床考虑因素,如是否应该同时治疗大隐静脉(GSV)和ASV,在治疗反流的GSV时是否应该治疗正常的ASV,以及何时和如何治疗相关的曲张支流。了解了解剖、临床和技术方面的考虑因素,就可以制定治疗方案,优化 ASV 回流患者的长期疗效:最终,治疗方案应在以患者为中心的讨论中针对这些变量进行调整。
{"title":"The anterior saphenous vein. Part 4. Clinical and technical considerations in treatment. Endorsed by the American Vein and Lymphatic Society, the American Venous Forum, and the International Union of Phlebology.","authors":"Edward M Boyle, Rachel Drgastin, Nicos Labropoulos, Alberto Caggiati, Antonios Gasparis, Suat Doganci, Mark Meissner","doi":"10.1177/02683555231223063","DOIUrl":"10.1177/02683555231223063","url":null,"abstract":"<p><strong>Background: </strong>The decision to treat a refluxing anterior saphenous vein (ASV) should be a clinical decision based on the assessment on the ASV's contribution to patient's signs and symptoms. Once the decision to treat has been made, there are anatomic, clinical, and technical considerations in treatment planning.</p><p><strong>Methods: </strong>Clinical scenarios were discussed by a panel of experts and common anatomic, clinical, and technical considerations were identified.</p><p><strong>Results: </strong>There are unique clinical considerations such as whether both the great saphenous vein (GSV) and ASV should be concomitantly treated, if a normal ASV should be treated when treating a refluxing GSV and when and how to treat the associated tributary varicose tributaries. Being aware of the anatomic, clinical, and technical considerations allows development of a treatment plan that optimizes long-term outcomes in patients with ASV reflux.</p><p><strong>Conclusion: </strong>Ultimately the treatment plan should be tailored to address these types of variables in a patient-centered discussion.</p>","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"333-341"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11129528/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138833884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Indications, contraindications, side effects, general assessment, and outlook for the future: An International Compression Club survey. 适应症、禁忌症、副作用、总体评估和未来展望:国际压力俱乐部调查。
Pub Date : 2024-06-01 Epub Date: 2024-02-01 DOI: 10.1177/02683555241228899
Mosti Giovanni, Namislo Angrit, Benigni Jean Patrick, Da Matta Eduardo, Partsch Hugo, Schmitz Martin, Abel Martin

Background: The effectiveness of compression therapy (CT) and the best compression modality choice are questioned in many clinical stages of chronic venous disease (CVD). This work aims to obtain information on indications, contraindications, and the best treatment option for CT in different clinical scenarios of CVD.

Method: An online survey was made among members of the International Compression Club, experts in CT.

Results: The experts apply CT in all clinical stages of CVD, even when evidence is missing. Regarding compression materials, experts use inelastic materials in the advanced stages of CVD and compression stockings in the early or chronic stages of CVD.

Conclusion: The authors highlight the gap between experts' practical use of CT and evidence-based medicine results. They also suggested that, given the cost of randomized clinical trials aimed at specifying specific indications for different devices, artificial intelligence could be used for large-scale practice surveys in the future.

背景:在慢性静脉疾病(CVD)的许多临床阶段,加压疗法(CT)的有效性和最佳加压方式的选择都受到质疑。本研究旨在获取有关 CT 在 CVD 不同临床情况下的适应症、禁忌症和最佳治疗方案的信息:方法:对国际压迫俱乐部成员、CT 专家进行在线调查:结果:专家们将 CT 应用于心血管疾病的所有临床阶段,即使缺乏证据。关于压力材料,专家们在心血管疾病晚期阶段使用无弹性材料,在心血管疾病早期或慢性阶段使用压力袜:作者强调了专家对 CT 的实际使用与循证医学结果之间的差距。他们还建议,考虑到旨在明确不同设备具体适应症的随机临床试验的成本,未来可将人工智能用于大规模实践调查。
{"title":"Indications, contraindications, side effects, general assessment, and outlook for the future: An International Compression Club survey.","authors":"Mosti Giovanni, Namislo Angrit, Benigni Jean Patrick, Da Matta Eduardo, Partsch Hugo, Schmitz Martin, Abel Martin","doi":"10.1177/02683555241228899","DOIUrl":"10.1177/02683555241228899","url":null,"abstract":"<p><strong>Background: </strong>The effectiveness of compression therapy (CT) and the best compression modality choice are questioned in many clinical stages of chronic venous disease (CVD). This work aims to obtain information on indications, contraindications, and the best treatment option for CT in different clinical scenarios of CVD.</p><p><strong>Method: </strong>An online survey was made among members of the International Compression Club, experts in CT.</p><p><strong>Results: </strong>The experts apply CT in all clinical stages of CVD, even when evidence is missing. Regarding compression materials, experts use inelastic materials in the advanced stages of CVD and compression stockings in the early or chronic stages of CVD.</p><p><strong>Conclusion: </strong>The authors highlight the gap between experts' practical use of CT and evidence-based medicine results. They also suggested that, given the cost of randomized clinical trials aimed at specifying specific indications for different devices, artificial intelligence could be used for large-scale practice surveys in the future.</p>","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"342-352"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11129525/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139674016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The anterior saphenous vein. Part 1. A position statement endorsed by the American Vein and Lymphatic Society, the American Venous Forum, and the International Union of Phlebology. 隐静脉前端。第一部分。由美国静脉与淋巴协会、美国静脉论坛和国际静脉学联盟共同认可的立场声明。
Pub Date : 2024-06-01 Epub Date: 2024-01-03 DOI: 10.1177/02683555231224529
Mark Meissner, Edward M Boyle, Nicos Labropoulos, Alberto Caggiati, Rachel Drgastin, Suat Doganci, Antonios Gasparis

Background: There is a lack of clarity regarding the terminology of the anterior accessory saphenous vein (AASV) that can impact treatment outcomes. Although use of the word "accessory" implies that the vein is a superficial tributary, evidence supports its role as a truncal vein, similar to the great and small saphenous veins, and warranting a change in terminology.

Methods: A multisocietal panel was convened by the American Vein and Lymphatic Society (AVLS), the Union International of Phlebology (UIP), and the American Venous Forum (AVF). The group was charged with reviewing the existing anatomic and clinical literature pertaining to the term "anterior accessory saphenous vein" and to consider the need for alternative terminology.

Conclusion: Based on the insights gathered from the literature review and extensive discussions, the panel recommends changing the terminology such that the "anterior accessory saphenous vein" (AASV) now be designated the anterior saphenous vein (ASV).

背景:关于大隐前静脉(AASV)的术语不够明确,这可能会影响治疗效果。虽然使用 "附属 "一词意味着该静脉是浅表支流,但有证据支持其作为躯干静脉的作用,与大隐静脉和小隐静脉类似,因此有必要改变术语:方法:美国静脉和淋巴学会 (AVLS)、国际静脉学联盟 (UIP) 和美国静脉论坛 (AVF) 召集了一个多社会小组。该小组负责审查与 "隐静脉前支 "一词相关的现有解剖和临床文献,并考虑是否需要其他术语:根据从文献回顾和广泛讨论中收集到的见解,专家组建议更改术语,将 "隐静脉前方附属静脉"(AASV)更名为 "隐静脉前方静脉"(ASV)。
{"title":"The anterior saphenous vein. Part 1. A position statement endorsed by the American Vein and Lymphatic Society, the American Venous Forum, and the International Union of Phlebology.","authors":"Mark Meissner, Edward M Boyle, Nicos Labropoulos, Alberto Caggiati, Rachel Drgastin, Suat Doganci, Antonios Gasparis","doi":"10.1177/02683555231224529","DOIUrl":"10.1177/02683555231224529","url":null,"abstract":"<p><strong>Background: </strong>There is a lack of clarity regarding the terminology of the anterior accessory saphenous vein (AASV) that can impact treatment outcomes. Although use of the word \"accessory\" implies that the vein is a superficial tributary, evidence supports its role as a truncal vein, similar to the great and small saphenous veins, and warranting a change in terminology.</p><p><strong>Methods: </strong>A multisocietal panel was convened by the American Vein and Lymphatic Society (AVLS), the Union International of Phlebology (UIP), and the American Venous Forum (AVF). The group was charged with reviewing the existing anatomic and clinical literature pertaining to the term \"anterior accessory saphenous vein\" and to consider the need for alternative terminology.</p><p><strong>Conclusion: </strong>Based on the insights gathered from the literature review and extensive discussions, the panel recommends changing the terminology such that the \"anterior accessory saphenous vein\" (AASV) now be designated the anterior saphenous vein (ASV).</p>","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"310-312"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11129512/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139089867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The anterior saphenous vein. Part 3. Systematic review of the literature and payor coverage policies. Endorsed by the American Vein and Lymphatic Society, the American Venous Forum and the International Union of Phlebology. 隐静脉前端。第 3 部分。文献和支付方承保政策的系统回顾。由美国静脉和淋巴协会、美国静脉论坛和国际静脉学联盟认可。
Pub Date : 2024-06-01 Epub Date: 2024-03-25 DOI: 10.1177/02683555231223281
Rachel Drgastin, Edward M Boyle, Nicos Labropoulos, Alberto Caggiati, Antonios Gasparis, Suat Doganci, Mark Meissner

Objective: The objective of this study is to systemically review the literature on Anterior Saphenous Vein (ASV) reflux treatment and insurance impediments to treatment coverage.

Methods: A literature search was performed using a PRISMA framework. In addition, a cross-sectional analysis of insurance policies for ASV treatment was evaluated.

Results: Published evidence and treatment considerations in the literature for ASV treatment are discussed. In 155 of 226 (68.6%) insurance policies reviewed coverage of ASV ablation was allowed while 62/226 (27.4%) did not specify coverage and 9/226 (4.0%) specified ASV treatment was not covered. Of the 155 that provide ASV coverage, 98 (62.2%) provide coverage with criteria such as requiring prior treatment of the great saphenous vein.

Conclusions: Vein treatment experts should continue to advocate to insurance carriers to update their varicose vein treatment policies to reflect the substantial clinical evidence so that patients with ASV reflux can be appropriately treated.

研究目的本研究的目的是系统回顾有关大隐静脉前段(ASV)回流治疗和治疗保险障碍的文献:方法:采用 PRISMA 框架进行文献检索。此外,还对 ASV 治疗的保险政策进行了横截面分析评估:结果:讨论了文献中已发表的 ASV 治疗证据和治疗注意事项。在所审查的 226 份保险单中,有 155 份(68.6%)允许 ASV 消融治疗,62/226(27.4%)份未明确说明承保范围,9/226(4.0%)份明确说明不承保 ASV 治疗。在 155 家承保 ASV 的保险公司中,有 98 家(62.2%)的承保标准要求事先治疗大隐静脉:静脉治疗专家应继续倡导保险公司更新其静脉曲张治疗政策,以反映大量临床证据,从而使 ASV 回流患者得到适当的治疗。
{"title":"The anterior saphenous vein. Part 3. Systematic review of the literature and payor coverage policies. Endorsed by the American Vein and Lymphatic Society, the American Venous Forum and the International Union of Phlebology.","authors":"Rachel Drgastin, Edward M Boyle, Nicos Labropoulos, Alberto Caggiati, Antonios Gasparis, Suat Doganci, Mark Meissner","doi":"10.1177/02683555231223281","DOIUrl":"10.1177/02683555231223281","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study is to systemically review the literature on Anterior Saphenous Vein (ASV) reflux treatment and insurance impediments to treatment coverage.</p><p><strong>Methods: </strong>A literature search was performed using a PRISMA framework. In addition, a cross-sectional analysis of insurance policies for ASV treatment was evaluated.</p><p><strong>Results: </strong>Published evidence and treatment considerations in the literature for ASV treatment are discussed. In 155 of 226 (68.6%) insurance policies reviewed coverage of ASV ablation was allowed while 62/226 (27.4%) did not specify coverage and 9/226 (4.0%) specified ASV treatment was not covered. Of the 155 that provide ASV coverage, 98 (62.2%) provide coverage with criteria such as requiring prior treatment of the great saphenous vein.</p><p><strong>Conclusions: </strong>Vein treatment experts should continue to advocate to insurance carriers to update their varicose vein treatment policies to reflect the substantial clinical evidence so that patients with ASV reflux can be appropriately treated.</p>","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"325-332"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11129522/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140290131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Phlebology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1